Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

178
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
178
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

130
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
130
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

94
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
94
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

79
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
79
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

104
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
104

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel maternal prenatal risk index to predict mortality-weighted severe maternal morbidity at hospitalization: a retrospective cohort study.

Lancet regional health. Americas·2026
Same author

Information-Based Composite Likelihood Method for Hybrid Meta-Analysis Integrating Individual Participant Data and Aggregated Data.

Statistics in medicine·2026
Same author

Vaccine efficacy estimands and power considerations.

Statistical methods in medical research·2026
Same author

Canopy2: Tumor Phylogeny Inference by Bulk DNA and Single-Cell RNA Sequencing.

Statistics in biosciences·2026
Same author

Mortality-weighted severe maternal morbidity: a novel approach to assessing maternal health outcomes.

BMC pregnancy and childbirth·2025
Same author

Pair-Feeding Study Designs Can Create Biases and Inflate Type I Error Rates: A Simulation Study.

Obesity (Silver Spring, Md.)·2025
Same journal

Risk estimation and dynamic prediction using discrete-time joint models for longitudinal and multistate data with interval and state censoring.

Biostatistics (Oxford, England)·2026
Same journal

A Bayesian functional concurrent zero-inflated Dirichlet-multinomial regression model with application to infant microbiome.

Biostatistics (Oxford, England)·2026
Same journal

Towards optimal environmental policies: policy learning under arbitrary bipartite network interference.

Biostatistics (Oxford, England)·2026
Same journal

Multilevel functional quantile principal component analysis.

Biostatistics (Oxford, England)·2026
Same journal

Adaptive transfer learning for time-to-event modeling with applications in disease risk assessment.

Biostatistics (Oxford, England)·2026
Same journal

High-dimensional test for one-sided hypotheses.

Biostatistics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Jul 17, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

Bayesian joint models for multi-regional clinical trials.

Nathan W Bean1, Joseph G Ibrahim1, Matthew A Psioda1

  • 1Department of Biostatistics, University of North Carolina, Chapel Hill, NC, USA.

Biostatistics (Oxford, England)
|September 5, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces a novel Bayesian joint modeling approach for multi-regional clinical trials (MRCTs). This method enhances statistical power for global treatment effect analysis by borrowing information across regions.

Keywords:
Bayesian clinical trialsBayesian model averagingJoint modelsLEADER trialLaplace approximationMulti-regional clinical trials

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

Related Experiment Videos

Last Updated: Jul 17, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Pharmaceutical Research

Background:

  • Multi-regional clinical trials (MRCTs) are increasingly used to expedite global drug development.
  • Challenges in MRCTs include small regional sample sizes, necessitating statistical methods for information borrowing, as suggested by ICH E17 guidance.
  • Existing methods may not fully leverage available data across diverse regions.

Purpose of the Study:

  • To develop and evaluate a novel statistical approach for joint analysis of survival and longitudinal data in MRCTs.
  • To implement information borrowing across regions using Bayesian model averaging within a joint modeling framework.
  • To assess the performance of this approach in improving the detection of global treatment effects.

Main Methods:

  • Development of a joint model for time-to-event and longitudinal outcomes in the MRCT context.
  • Application of Bayesian model averaging for information borrowing across regions.
  • Utilizing Laplace's method for integration over random effects and approximating posterior distributions.
  • Conducting simulation studies to compare the proposed method with traditional survival analysis.

Main Results:

  • The proposed joint modeling approach demonstrated an increased rejection rate for the global treatment effect compared to analyzing survival data alone in simulations.
  • The method effectively integrates survival and longitudinal data, allowing for information sharing across regions.
  • Successful application to a real-world cardiovascular outcomes MRCT dataset.

Conclusions:

  • Bayesian joint modeling with information borrowing offers a statistically robust approach for analyzing MRCT data.
  • This method can enhance the efficiency and power of global treatment effect evaluation in pharmaceutical development.
  • The approach provides a valuable tool for optimizing the design and analysis of future MRCTs.